Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLRN | KROS | ALXO | ||
| Company | Acelyrin Inc | Keros Therapeutics Inc | Alx Oncology Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.24 | 11.72 | 1.6700 | ||
| High | 2.36 | 11.84 | 1.8000 | ||
| Low | 2.20 | 11.60 | 1.6500 | ||
| Latest | 2.27 | 11.66 | 1.7500 | ||
| Change | +0.04 | -0.01 | +0.0800 | ||
| % Change | +1.79% | -0.09% | +4.79% | ||
| Volume | 4,076,500 | 225,700 | 2,242,200 | ||
| 20-Day Average Volume | 1,091,300 | 388,225 | 1,095,700 | ||
| Previous Close | 2.23 | 11.67 | 1.6700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.33 | 11.52 | 1.8728 | ||
| 20-Day Raw Stochastic | 45.16% | 55.83% | 23.81% | ||
| 20-Day Relative Strength | 47.29 | 42.40 | 43.95 | ||
| Weighted Alpha | -28.45 | -30.45 | +52.08 | ||
| Today's Opinion | 88% Sell | 72% Sell | 24% Buy | ||
| Previous Opinion | 88% Sell | 72% Sell | 8% Buy | ||
| Last Month's Opinion | 100% Sell | 72% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.61% since 05/13/25 | +4.57% since 04/13/26 | unch since 04/13/26 | ||
| Low | 1.95 on 05/15/25 | 11.17 on 04/14/26 | 1.6050 on 04/15/26 | ||
| High | 2.36 on 05/20/25 | 12.00 on 04/17/26 | 1.8200 on 04/14/26 | ||
| 1-Month | |||||
| %Chg | +3.18% since 04/17/25 | +6.39% since 03/20/26 | -19.72% since 03/20/26 | ||
| Low | 1.95 on 05/15/25 | 10.41 on 03/30/26 | 1.6000 on 04/10/26 | ||
| High | 2.65 on 05/01/25 | 12.65 on 04/08/26 | 2.2300 on 03/24/26 | ||
| 3-Month | |||||
| %Chg | +4.61% since 02/20/25 | -36.73% since 01/20/26 | +32.58% since 01/20/26 | ||
| Low | 1.95 on 05/15/25 | 10.41 on 03/30/26 | 1.3180 on 01/21/26 | ||
| High | 2.94 on 04/02/25 | 19.94 on 01/23/26 | 2.6600 on 02/19/26 | ||
| 6-Month | |||||
| %Chg | -48.76% since 11/20/24 | -23.24% since 10/20/25 | +6.06% since 10/20/25 | ||
| Low | 1.85 on 02/11/25 | 10.41 on 03/30/26 | 1.0500 on 11/07/25 | ||
| High | 5.03 on 11/25/24 | 22.55 on 12/08/25 | 2.6600 on 02/19/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 229,166 | 230,109 | 219,785 | ||
| Shares Outstanding, K | 100,954 | 19,718 | 131,608 | ||
| Annual Sales | 0 | 244,060,000 | 0 | ||
| Annual Net Income | -248,230,000 | 87,010,000 | -101,700,000 | ||
| Last Quarter Sales | 0 | 390,000 | 0 | ||
| Last Quarter Net Income | -55,260,000 | -23,460,000 | -22,850,000 | ||
| 60-Month Beta | 1.07 | 0.98 | 0.49 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 05/14/25 | -0.86 on 03/04/26 | -0.42 on 02/27/26 | ||
| Latest Earnings Date | 08/12/25 | 05/05/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.44 | 0.00 | ||